Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Secondary cancers
Closed
Phase 1
This trial is looking at a new combination of treatment for kidney cancer that has spread elsewhere in the body or if surgery to remove it is not possible.
It is for people who have already had an immunotherapy.
Recruitment start: 26 January 2021
Recruitment end: 20 July 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Tom Waddell
Merck, Sharp & Dohme
The Christie NHS Foundation Trust
Cancer Research UK Manchester Institute Cancer Biomarker Centre
Last reviewed: 23 Jul 2022
CRUK internal database number: 16929